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Abstract
Background: It is well-known that ocular vestibular evoked myogenic potentials (oVEMPs) predominantly reflect
utricular function whilst cervical vestibular evoked myogenic potentials (cVEMPs) reflect saccular function. To date,
there are no published reports on the systemic evaluation of utricular and saccular function in benign paroxysmal
positional vertigo (BPPV), nor are there any reports on the differences in VEMPs between patients with recurrent and
non-recurrent BPPV. The aim of this study was to evaluate the difference in cervical and ocular (c/o)VEMPs between
patients with BPPV and normal controls, as well as between patients with recurrent and non-recurrent BPPV.
Methods: Thirty patients with posterior canal BPPV and 30 healthy subjects (as normal controls) were prospectively
enrolled. cVEMP and oVEMP testing using 500 Hz tone-burst stimuli were performed on all. VEMP tests were repeated
3 times on each subject to ensure reliability and reproducibility of responses. VEMPs were defined as present or absent.
Abnormal VEMP was defined by lack of VEMP response.
Results: In the control group, abnormal cVEMPs responses were detected in 6.67 % and abnormal oVEMPs responses
were detected in 3.34 %. In BPPV patients (10 with recurrent BPPV, 20 with non-recurrent BPPV), abnormal cVEMPs
responses were detected in 30 % and abnormal oVEMPs responses were detected in 56.7 %. More patients with BPPV
showed abnormal responses in c/oVEMPs as compared to the control group (p < 0.05). oVEMPs was more often
abnormal as compared to cVEMPs in BPPV patients (p < 0.05). There was no statistical difference between abnormal
cVEMP responses in non-recurrent BPPV patients (25 %) and recurrent BPPV patients (40 %) (p > 0.05). Differences in
abnormal oVEMP responses (non-recurrent BPPV, 40 %; recurrent BPPV, 90 %) were significant (p < 0.05).
Conclusion: An increased occurrence of abnormal c/oVEMP recordings appeared in BPPV patients, possibly as a
result of degeneration of the otolith macula. oVEMPs were more often abnormal in BPPV patients as compared to
cVEMPs, suggesting that utricular dysfunction may be more common than saccular dysfunction. Furthermore, oVEMP
abnormalities in the recurrent BPPV group were significantly higher than those in the non-recurrent BPPV
group. Assessment of c/oVEMPs in BPPV patients may therefore be of prognostic value in predicting
likelihood of BPPV recurrence.
Keywords: Cervical/ocular vestibular evoked myogenic potentials (c/oVEMPs), Benign paroxysmal positional
vertigo (BPPV), Utricular, Saccular
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Background
Vestibular evoked myogenic potential (VEMP) is a short-
latency myogenic response which is evoked by brief pulses
of air-conducted (AC) sound, bone-conducted (BC) vibra-
tion or electrical stimulation and recorded using surface
electrodes placed over muscles. Cervical vestibular evoked
myogenic potentials (cVEMPs), which are a manifestation
of the vestibulo-colic reflex, predominantly the sacculo-
collic reflex, are assessed by measuring electromyographic
(EMG) activity from surface electrodes placed over the
tonically activated sternocleidomastoid (SCM) muscles. In
1992 and 1994, cVEMPs was first described by Colebatch
and Halmagyi [1, 2], who measured electromyographic
(EMG) activity from the sternocleidomastoid (SCM) mus-
cles following vestibular stimulation with brief pulses of
sound (clicks). In 1995, Halmagyi et al. [3]. elicited
cVEMPs by tapping the forehead with a clinical reflex
hammer. The responses had the same biphasic waveform
as the AC cVEMPs and were vestibular-dependent, but
were also present in patients with conductive hearing loss
as the stimulus bypasses the middle ear conductive
mechanism. In 2000, Sheykholeslami et al. [4]. recorded
cVEMPs using BC sound delivered to the mastoid bone
with a clinical bone conductor.
In 2005 and 2007, Rosengren [5] and Todd [6] re-
corded the short latency potentials from around the eyes
by bone-conducted sound (BCS) and demonstrated that
it can also be recorded from the extraocular muscles as
part of the vestibulo-ocular reflex (VOR). It was recently
reported that ocular VEMPs (oVEMPs) are produced by
synchronous activity in the extraocular muscles in re-
sponse to stimulation, including sound [7]. Assessment
of oVEMPs is used as a clinical test for the vestibular
system because it provides information on otolith func-
tion. A more recent study reported that oVEMPs in re-
sponse to air-conducted sound (ACS) reflect functions
of different parts of the vestibular labyrinth from
cVEMPs in response to ACS; that is, oVEMPs predom-
inantly reflect utricular functions while cVEMPs reflect
saccular functions [8].
Canalolithiasis and cupulolithiasis have been consid-
ered as possible mechanisms in the etiology of benign
paroxysmal positional vertigo (BPPV) [9, 10]. In addition
to these mechanisms, otolith dysfunction has also been
suggested as a possible mechanism of BPPV [11–13].
The detachment of the otoconia from the otolith macula
is post-viral or post-traumatic in some cases; however, in
many instances it seems to occur without an identifiable
cause [14]. The finding that BPPV patients had significantly
higher incidence of abnormal amplitudes in cVEMPs com-
pared with controls has been reported [15, 16], suggesting
that BPPV patients have more saccular damage than
controls. However, the systemic evaluation of utricular
and saccular damage in BPPV patients has never been
reported. There is a significant rate of BPPV recurrence
after initial resolution. The reported recurrence rate dur-
ing a 1-year follow-up period ranged from 10 % to 18 %
[17, 18]. To date, there are no reports on the differences
in VEMPs between patients with recurrent and non-
recurrent BPPV. The aim of this study is to evaluate the
difference in c/oVEMPs between patients with BPPV and
controls, as well as between patients with recurrent and
non-recurrent BPPV. The other objective of this study is




Ethical approval was received from the Ethics Committee
of Affiliated Yantai Yuhuangding Hospital of Qingdao
University Medical College. We prospectively enrolled 30
consecutive patients from the Dizziness Clinic, affiliated
Yantai Yuhuangding Hospital of Qingdao University
Medical College, who were diagnosed with posterior canal
BPPV (canalolithiasis, nystagmus duration < 60 s) between
January 2013 and June 2014. Follow-up was for 1 year.
Patients were divided into two groups according to
recurrence - 20 non-recurrent BPPV patients and 10
recurrent BPPV patients. Recurrence was defined as BPPV
that occurred more than 1 month after a successful repo-
sitioning manoeuvre during the 1 year follow-up period.
The diagnosis of BPPV and the affected side was based on
the typical nystagmus seen during the Dix-Hallpike man-
euver. The control subjects were all volunteers from our
normal outpatient clinic who had no otological disease.
Patients with a history of hearing loss, other vestibular
disorders and >60 years old were excluded. Informed
consent was obtained from each subject according to the
Declaration of Helsinki.
cVEMPs
Cervical vestibular evoked myogenic potentials (cVEMPs)
testing was performed on both sides for all patients and
controls. In the cVEMPs test, all subjects were placed in a
sitting position and asked to rotate their head away from
the stimulated side so as to record electromyographic ac-
tivity over tonically activated sternocleidomastoid (SCM)
muscles. Surface EMG activity was recorded with superfi-
cial electrodes placed on the middle third of the SCM,
with the reference electrode placed on the upper third of
the sternum and the ground electrode on the middle of
the forehead. Using a Bio-Logic Navigator Pro, 90 dB nHL
500 Hz tone bursts were presented through headphones,
and the EMG signal was amplified and bandpass filtered
(30–1500 Hz). The analysis window was 100 ms wide and
responses to 120 stimuli were averaged. cVEMP tests were
repeated 3 times on each subject to ensure reliability and
reproducibility of responses. The amplitude of the first
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positive–negative peak (P13–N23) was recorded. Absence
of a meaningful wave form with p13 and n23 was defined
as ‘no response’. Abnormality was strictly defined as a
cVEMP pattern of ‘no response,’ which meant the absence
of a meaningful waveform with P13 and N23.
oVEMPs
Ocular vestibular evoked myogenic potentials (oVEMPs)
testing was performed on both sides for all patients and
controls. In the oVEMPs test, all subjects assumed a
sitting position and the subject was instructed to look
superomedially at a small fixed target 1 m from the eyes.
The visual angle was approximately 30°, which has been
found to elicit the largest responses compared with
other eye positions [19]. The active electrodes were
placed on the face, oriented vertically and approximately
1 cm below the center of the lower eyelid just inferior to
the contralateral eye for sound stimulation. The refer-
ence electrode was placed about 1 cm below the active
electrode on the cheek, and the ground electrode was
placed on the forehead. Each subject’s eyes remained
fixed on the target throughout the test. Using a Bio-
Logic Navigator Pro, 95 dB nHL 500 Hz tone bursts
were presented through headphones, and the EMG sig-
nal was amplified and bandpass filtered (10–300 Hz).
The analysis window was 100 ms wide and responses to
120 stimuli were averaged. oVEMP tests were repeated 3
times on each subject to ensure reliability and repro-
ducibility of responses. The initial negative–positive
biphasic waveform comprised peaks N1 and P1. We ana-
lyzed the waveforms of N1 and P1 at the maximal inten-
sity of stimulation. Abnormality was strictly defined as
an oVEMP pattern of ‘no response,’ which meant an
absence of a meaningful waveform with N1 and P1.
Statistical analysis
A Fishers exact or Chi-squared test was used to analyze
the statistical significance of the inter-group difference
in the number of non- cVEMPs and oVEMPs responders
in the BPPV and controls groups. A p value of < 0.05 in-
dicated statistical significance.
Results
The ages ranged from 34 to 55 years (mean 45.5, 12
men and 18 women) in patients with BPPV. The control
group consisted of 30 normal subjects (10 men and 20
women; mean age 42.2 years; age range 30–60 years).
Demographic data for BPPV and control groups are
summarized in Table 1. There were no significant dif-
ferences in age and sex ratio between the two groups
(p > 0.05). Testing of VEMPs was performed on both sides
in all BPPV patients and controls. Only one patient with
BPPV showed bilateral abnormalities, so only ipsilesional
data are presented. In the control group, abnormal
cVEMP responses were detected in 2 of 30 (6.67 %) sub-
jects and abnormal oVEMP responses were detected in 1
of 30 (3.34 %) subjects (Table 2).
cVEMP abnormalities in BPPV patients
Abnormal cVEMP responses were detected in 9 of 30
(30 %) BPPV subjects (Table 3). More patients with
BPPV showed abnormal responses in cVEMPs as
compared to the controls (p < 0.05) (Fig. 1). In cVEMPs
testing, abnormalities were detected in 5 of 20 (25 %) in
the non-recurrent BPPV group and in 4 of 10 (40 %)
subjects in the recurrent BPPV group; the difference
between the two groups was not significant (p > 0.05)
(Fig. 2).
oVEMP abnormalities in BPPV patients
Abnormal oVEMP responses were detected in 17 of 30
(56.7 %) subjects in BPPV group (Table 4). More patients
with BPPV showed abnormal responses in oVEMPs as
compared to the controls (p < 0.05) (Fig. 3). In oVEMPs
testing, abnormalities were detected in 8 of 20 (40 %) in
the non-recurrent BPPV group and in 9 of 10 (90 %)
subjects in the recurrent BPPV group; the difference be-
tween the two groups was significant (p < 0.05) (Fig. 4).
Comparison of oVEMPs with cVEMPs within BPPV patients
Abnormal oVMEPs responses were detected in 17 of 30
(56.7 %) subjects in BPPV group while abnormal
cVMEPs responses were detected in 9 of 30 (30 %). The
abnormal results for oVEMPs showed a higher percent-
age than those for cVEMPs in BPPV patients (p < 0.05)
(Fig. 5).
Discussion
The exact pathophysiology of BPPV remains unclear.
Several studies have previously suggested the cause
being dislodgement of otoconia from the gelatinous layer
of the otolithic membrane [20], which may be associated
with osteopenia and osteoporosis [21]. At present,
Table 1 Demographic features of subjects in BPPV and
control groups
Group feature Control BPPV
Number 30 30
Age* 42.2 ± 8.7 45.5 ± 9.2
Sex (M:F)* 10:20 12:18
BPPV Benign paroxysmal positional vertigo. *p > 0.05
Table 2 The abnormal c/oVEMP responses details in control group
VEMP test Abnormal Normal Total Percent
cVEMP 2 28 30 6.67 %
oVEMP 1 29 30 3.34 %
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cVEMPs which are evoked by air-conducted sound (ACS),
are widely used to evaluate the function of saccule and
inferior vestibular nerve by recording the inhibitory po-
tential from the SCM. oVEMPs are also evoked by ACS.
Although its origin is controversial, it was recently re-
ported to be involved in the stimulation of the utricular
macula. Curthoys et al. [7]. and Shin et al. [22]. reported
that the oVEMP evoked by ACS may be predominantly
mediated by the superior vestibular nerve due to the acti-
vation of the utricular receptors. In BPPV, the degenera-
tive process of otolith not only affects the macula of the
utricle and causes detachment of the otoliths, but might
also affect the macula of the saccule. Von Brevern et al.
[23]. reported that utricular dysfunction, which is associ-
ated with idiopathic BPPV, possibly results from de-
generation of the utricular macula. Our study results
supports this hypothesis with regards to utricular dysfunc-
tion in BPPV patients. However, they failed to demon-
strate any significant change in saccular function. Our
study is in concordance with several other studies that
reported on cVEMPs in patients diagnosed with BPPV
[15, 24]. Korres S et al. [24]. found an increased occur-
rence of abnormal cVEMP recordings in BPPV patients
and attributed this to possible degeneration of the saccular
macula, which is part of the neural VEMP pathway. With
regards to the amplitude and latency values of VEMPs,
there are many factors that can affect these values such as
basic muscle activity, patient’s position, and general
conditions [25, 26]. Because of their non-specific value in
VEMPs testing, we used a qualitative approach to VEMPs
results. Our definition for abnormal VEMP is an absence
of VEMP response. The main objective in this study was
to report c/o VEMPs findings in BPPV patients and to
verify some clinical characteristics of BPPV in VEMPs.
We evaluated both the function of utricle and saccule by
measuring c/oVEMPs.
In our study, we found that patients with BPPV
showed higher rate of abnormal responses in c/oVEMPs
by stimulation on their affected side than the controls.
Hong et al. 16 reported that 24.5 % of patients with
BPPV showed abnormal cVEMP responses, such as P13
latency prolongation and VEMP amplitude asymmetry
on the affected side. The incidence of abnormal response
of cVEMP in our study was 30 %, which is similar with
that reported. Brandt et al. [27]. reported that most
recurrences were diagnosed within the first year after
treatment. Hence, 1 year was chosen as the follow up
period in our study. In cVEMPs testing, abnormalities
were detected in 25 % of subjects in the non-recurrent
BPPV group and in 40 % of subjects in the recurrent
BPPV group. Although there was a higher rate of abnor-
mality in the recurrent BPPV group, the difference be-
tween the two groups was not significant (p > 0.05). This
suggests that BPPV recurrence may not be related to
saccular damage, although another possibility may be
that larger numbers of patients are needed in the study
Table 3 cVEMPs abnormalities in BPPV groups
BPPV group Abnormal Normal Total
NG 5 (25 %) 15 (75 %) 20
RG 4 (40 %) 6 (60 %) 10
Total 9 (30 %) 21 (70 %) 30
NG Nonrecurrent group, RG Recurrent group, NG VS RG: (p > 0.05)
Fig. 1 cVEMP abnormalities difference between BPPV and control
groups. Legend 1: Abnormal cVEMPs responses were detected in 30 %
BPPV subjects. In control volunteers, abnormal cVEMPs responses were
detected in 6.67 % subjects. More of the patients with BPPV showed
abnormal responses in cVEMPs than the controls (p < 0.05)
Fig. 2 cVEMP abnormalities difference between nonrecurrent and
recurrent BPPV groups. Legend 2: In cVEMPs testing, abnormalities
were detected in 25 % in the nonrecurrent BPPV group and in 40 %
subjects in the recurrent BPPV group; the difference between the
two groups was no significant (p > 0.05). (NG Nonrecurrent group,
RG Recurrent group)
Table 4 oVEMP abnormalities in BPPV groups
BPPV group Abnormal Normal Total
NG 8 (40 %) 12 (60 %) 20
RG 9 (90 %) 1 (10 %) 10
Total 17 (56.7 %) 13 (43.3 %) 30
NG Nonrecurrent group, RG Recurrent group; NG VS RG: (p < 0.05)
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to demonstrate a significant difference. Our findings
differ from those of Lee JD et al., who reported a higher
incidence (31.25 %) of cVEMP abnormality in recurrent
BPPV than non-recurrent BPPV patients [28].
In oVEMPs testing, abnormal response rate was
significantly higher in recurrent BPPV patients than
non-recurrent BPPV patients, whilst the difference in
cVEMPs between the 2 groups was not significant. This
suggests that the incidence of utricular dysfunction is
higher than saccular dysfunction in recurrent BPPV pa-
tients. Clinicians should be aware of the risk of recurrent
BPPV in these patients with abnormal oVEMPs and be
able to counsel patients appropriately. In our clinical
practice, the risk of recurrence is emphasized after the
diagnosis of BPPV and strict follow up is recommended
for all patients. With our findings, we may now be able
to better predict which patients are more likely to have
BPPV recurrence.
In our study, there was a higher rate of abnormal
oVEMP results than cVEMP results in BPPV patients.
These findings support the possibility that utricular
function in BPPV patients is more heavily damaged than
saccular function. Utricular dysfunction seems to play an
essential role as an underlying mechanism contributing
to BPPV. Bremova T et al. [29]. measured oVEMP
amplitudes before and after repositioning manoeuvres in
BPPV patients and found significant increase in the
amplitudes following the manoeuvres whilst the cVEMPs
had no amplitude change.
VEMPs is a good method for evaluation of otolith
function; however, this test requires specialized equip-
ment and complicated procedures for separate analyses
of utricular and saccular function as the VOR gain
reduction is under the influence of both utricular and
saccular dysfunction, in addition to semicircular canal-
otolith interaction. In the present study, abnormalities in
oVEMPs was frequently detected. This finding is consist-
ent with the suggested underlying pathology of BPPV,
namely, degeneration of the utricular maculae leading to
dislodging of otoconia. Those ears showing abnormal
oVEMP as well as cVEMP might have severe changes
causing dysfunction of the utricle and the saccule.
Considering the controversy in the stability and repeat-
ability of c/oVEMPs, we defined abnormal c/oVEMPs as
absent responses in our study. As a result, we did not ana-
lyse the latency and amplitude of the waves in c/oVEMPs.
The main limitation of our study is the small number of
BPPV patients. As the incidence of BPPV is higher in the
elderly and the average age of our study patients was
under 60 years, there is a potential bias in the research. In
future research, a larger sample size will be obtained such
that quantitative analysis of otolith function in BPPV pa-
tients can be performed.
Conclusion
An increased occurrence of abnormal c/oVEMP record-
ings appeared in BPPV patients, possibly as a result of
degeneration of the otolith macula. oVEMPs were more
Fig. 3 oVEMP abnormalities difference between BPPV and control
groups. Legend 3: In control volunteers, abnormal oVMEPs responses
was detected in 3.34 % subjects. Abnormal oVMEP responses were
detected in 56.7 % subjects in BPPV group. More of the patients
with BPPV showed abnormal responses in oVEMPs than the
controls (p < 0.05)
Fig. 4 oVEMP abnormalities difference between nonrecurrent and
recurrent BPPV groups. Legend 4: In oVEMPs testing, abnormalities
were detected in 40 % in the nonrecurrent BPPV group and in 90 %
subjects in the recurrent BPPV group; the difference between the
two groups was significant (p < 0.05). (NG Nonrecurrent group,
RG Recurrent group)
Fig. 5 Difference between oVEMP and cVEMP in BPPV groups.
Legend 5: Abnormal oVMEPs responses were detected in 56.7 %
subjects while abnormal cVMEPs responses were detected in 30 %
subjects in BPPV group. The abnormal results for oVEMPs showed a
higher percentage than those for cVEMPs in BPPV patients (p < 0.05)
Xu et al. Journal of Otolaryngology - Head and Neck Surgery  (2016) 45:12 Page 5 of 6
often abnormal in BPPV patients as compared to
cVEMPs, suggesting that utricular dysfunction may be
more common than saccular dysfunction. Furthermore,
oVEMP abnormalities in the recurrent BPPV group were
significantly higher than those in the non-recurrent
BPPV group. Assessment of c/oVEMPs in BPPV patients
may therefore be of prognostic value in predicting
likelihood of BPPV recurrence in these patients.
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